BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 25, 2025
Home » Authors » John Brosky

Articles by John Brosky

Big players sustain growth in a tough implant market

Oct. 29, 2008
By John Brosky
BERLIN, Germany – More than $625 million in sales was in play at the German Congress for Orthopedics and Trauma Surgery here, the largest share of which will go to American companies. (Medical Device Daily)
Read More

New designs are challenging traditional endoscopic usage

Oct. 24, 2008
By John Brosky
VIENNA, Austria — The evolution of surgical medical technology is headed down the path of de-evolution in the search for intelligent design. (Medical Device Daily)
Read More

Studies bolster PillCam as competition builds in sector

Oct. 23, 2008
By John Brosky
VIENNA, Austria — In the second year of full-blown competition for a capsule camera market it created in 2001 and enjoyed exclusively until 2006, Given Imaging (Yokneam, Israel) continues to roll out clinical trials hitting where its newly arrived competitors can not reach.(Medical Device Daily)
Read More

Evidence-based approach buoys Barrx's expansion in Europe

Oct. 22, 2008
By John Brosky
VIENNA – A California company secured its expansion into Europe with the release of a multi-center European study highlighted in the opening plenary session as United European Gastroenterology Week 2009 (UEGW) got under way here. (Medical Device Daily)
Read More

Novel device goes nuclear in the battle against restenosis

Oct. 21, 2008
By John Brosky
MUNICH, Germany — Restenosis, the reclosing of arteries opened after surgery interventions, continues to plague the plaque-busting vascular intervention techniques, defying even state-of-the-art drug-eluting stents (DES). (Medical Device Daily)
Read More

'Big chiefs' agree on key points in industry survey

Oct. 17, 2008
By John Brosky

In 'Brussels-speak,' med-tech firms outline their concerns

Oct. 16, 2008
By John Brosky

Med-tech industry groups seek more bandwidth for their voice

Oct. 15, 2008
By John Brosky

French Biotech Takes Stock as Financial Crisis Widens

Oct. 15, 2008
By John Brosky

Nobel Winner Urges Research Partnerships Against Diseases

Oct. 10, 2008
By John Brosky
Previous 1 2 … 73 74 75 76 77 78 79 80 81 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing